Risk for first onset depression in adults with congenital heart disease

Autor: Susanne J. Nielsen, Mikael Dellborg, Margda Waern, Zacharias Mandalenakis, Kok Wai Giang

Publikováno v: International Journal of Cardiology Congenital Heart Disease, Vol 9, Iss , Pp 100410- (2022)

Background: The long-term risk for depression among adults with congenital heart disease (ACHD) is unclear. Therefore, we assessed the risk for first onset of serious depression in patients with ACHD compared with a sex- and age-matched control popul

Externí odkaz: https://doaj.org/article/13bc8827717e44cd973e24bc96e9b10f

Stroke Risk Stratification in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting

Autor: Amar Taha, Susanne J. Nielsen, Stefan Franzén, Mary Rezk, Anders Ahlsson, Leif Friberg, Staffan Björck, Anders Jeppsson, Lennart Bergfeldt

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 10 (2022)

Background The CHA2DS2‐VASc (congestive heart failure, hypertension, age ≥75 years, diabetes, previous stroke or TIA [transient ischemic attack], vascular disease, age 65 to 74 years, sex category female; 2 indicates 2 points, otherwise 1 point)

Externí odkaz: https://doaj.org/article/7a45a14a63264a0c96f4b4f6dcf58d67

Socioeconomic Factors, Secondary Prevention Medication, and Long‐Term Survival After Coronary Artery Bypass Grafting: A Population‐Based Cohort Study From the SWEDEHEART Registry

Autor: Susanne J. Nielsen, Martin Karlsson, Erik Björklund, Andreas Martinsson, Emma C. Hansson, Carl Johan Malm, Aldina Pivodic, Anders Jeppsson

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 5 (2020)

Background Low income and short education have been found to be independently associated with inferior survival after coronary artery bypass grafting (CABG), whereas the use of secondary prevention medications is associated with improved survival. We

Externí odkaz: https://doaj.org/article/28317101c0674ffc92d1c28dac570cc4

Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial):Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial

Autor: Carl Johan Malm, Joakim Alfredsson, David Erlinge, Tomas Gudbjartsson, Jarmo Gunn, Stefan James, Christian H. Møller, Susanne J. Nielsen, Ulrik Sartipy, Theis Tønnessen, Anders Jeppsson

Publikováno v: Malm, C J, Alfredsson, J, Erlinge, D, Gudbjartsson, T, Gunn, J, James, S, Møller, C H, Nielsen, S J, Sartipy, U, Tønnessen, T & Jeppsson, A 2023, ' Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial) : Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial ', American Heart Journal, vol. 259, pp. 1-8 . https://doi.org/10.1016/j.ahj.2023.01.011

The TACSI trial (ClinicalTrials.gov Identifier: NCT03560310) tests the hypothesis that 1-year treatment with dual antiplatelet therapy with acetylsalicylic acid (ASA) and ticagrelor is superior to only ASA after isolated coronary artery bypass grafti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f7a6f71a77ccbf7eeaaa2f9bc02a86
https://curis.ku.dk/ws/files/347108374/1_s2.0_S0002870323000182_main.pdf

Decision‐Making in Seeking Emergency Care for Stroke Symptoms

Autor: Jenny Andersson, Sofie Jakobsson, Åsa Rejnö, Per‐Olof Hansson, Susanne J. Nielsen, Lena Björck

Publikováno v: Stroke: Vascular and Interventional Neurology. 2

Background Previous studies have shown that rapid treatment for stroke, especially ischemic stroke, reduces mortality and disability. The focus has mainly been on reducing time from arrival at hospital to start of treatment. However, the main reason

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86684f82fa468386ab005a8743fcf0be
https://doi.org/10.1161/svin.122.000376